Generics 161

Originals

Biosimilars

Medical devices

Nutraceuticals

Filters

Linezolid manufacturers

161 products found

Filters

161 products found

linezolid

Tablets, film coated 600 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Unavailable markets
Bolivia , Chile , Colombia , Costa Rica , Dominican Republic , El Salvador , Guatemala , Honduras , Nicaragua , Panama , Paraguay , Peru , Ukraine , Uruguay , Venezuela
Comments
DCP successful, RMS SE
Manufacturer #422

A pharmaceutical manufacturer based in the EU that has been active in 100+ countries selling its products in Europe, North America, Africa, the Middle East, and Asia for 40+ years. Main therapeutic areas include CNS, cardiovascular medication, and anti-infectives. The company's production lines are EU GMP-compliant. Key production lines are Rx and OTC. The company owns 20+ branches in Europe, Africa, and Asia.

Manufacturer usually replies in 1 days

linezolid

Solution for infusion 600 mg/300 ml

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP, Greece
Unavailable markets
Austria , Belgium , Bulgaria , Croatia , Cyprus , Czech Republic , Denmark , Estonia , Finland , France , Germany , Greece , Hungary , Iceland , Ireland , Italy , Kosovo , Latvia , Lithuania , Malta , Netherlands , Norway , Poland , Portugal , Romania , Slovakia , Spain , Sweden , United Kingdom , Vietnam
Available for
Distribution only
Comments
Product is not available for Europe
Manufacturer #298
This company is a global pharmaceutical and commercial organization that has been operating for over five decades. It specializes in injectable and prescription drug products, medical devices, and food supplements. Their manufacturing facilities are EU and US GMP approved. They have a strong presence in international markets, especially in Europe, North America, and Asia. The company also prides itself on its commitment to research and development of new products, particularly in the field of monoclonal antibodies. This commitment has earned them recognition and awards for their innovation and manufacturing excellence.

Manufacturer usually replies in 1 days

linezolid

Tablets, film coated 600 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Manufacturer #419

The manufacturer based in Europe, has decades of experience in the industry. They focus on a diverse range of products, including prescription drugs, over-the-counter medications, and medical devices. Their portfolio covers a variety of therapeutic areas, with key focuses on cardiovascular health, oncology, and pain management. The manufacturer holds numerous patents for their innovative products and adheres to strict GMP standards for both the European Union and the United States. They distribute their products across key regions in Europe, North America, and other international markets. Their production lines include solid oral dosage forms, injectables, and liquids, offering a wide range of treatment options for patients.

Manufacturer usually replies in 1 days

Want to see all 161 products?

Subscribe today to benefit from:

  • Streamlined product sourcing - the leading CTD dossiers database focused on finished dosage formulations

  • Direct negotiations - connect and negotiate directly with manufacturers without any brokerage fee

  • Increased profitability - secure the best commercial terms for your business by comparing offers from several manufacturers

Request Subscription

Linezolid

Linezolid is an antibiotic primarily used for treating infections resulting due to gram-positive bacteria resistant to other antibiotics. It is quite effective against most of the gram-positive bacteria that result in a disease such as Staphylococcus aureus. It is beneficial for treating infections of pneumonia and skin. However, it can also be used for treating other infections including drug-resistant tuberculosis. It is taken either by mouth or given by injection into a vein. Linezolid is quite safe when given for a short duration. It can be given to people of all ages including those with poor kidney function and liver disease. The common side effects noted are nausea, rash, diarrhea, and headache.
Linezolid works by suppressing bacterial protein production as a protein synthesis inhibitor. This either results in the death of the bacteria or inhibits the growth entirely. Although most of the antibiotics work this way, the exact mechanism of this drug is unique. It cuts down protein production entirely. This drug belongs to the oxazolidinone class of medications. Linezolid was approved for medical use in 2000. The wholesale cost of this drug in the developing world is around £2.31 per day. However, the wholesale cost elsewhere is around £11. It is a much cost-effective option in comparison to vancomycin.

Medical uses of Linezolid

The main use of this drug is in the treatment of severe infections resulting due to gram-positive bacteria that have developed resistance against other antibiotics. It cannot be used against bacteria that are sensitive to drugs having a narrow spectrum of activity such as cephalosporins and penicillins. This drug is called a reserve antibiotic as it can remain effective if it is used sparingly. It should be used as the last drug of resort against intractable infections. The manufacturers in the UK mention cSSSIs and pneumonia as the only indications during product labeling. The best thing about this drug is that it is safe and effective for use in newborns and children.

Synthesis of Linezolid

Linezolid manufacturers derive this drug from a synthetic process. It is not available in nature. Many approaches have been studied for the synthesis of this drug. The original method is lengthy and requires the use of expensive chemicals despite the good yield. The high cost of this drug is because of the expensive procedure involved in its synthesis. A cost-effective and concise mechanism was developed in 1998 by Upjohn. Later, an Indian pharmaceutical company called Dr. Reddy’s developed an atom-economical method in 1999.

History of Linezolid

The oxazolidinones have been known since the 1950s. Researchers discovered their antimicrobial properties in the 1970s. A series of derivatives of this chemical was patented by DuPont in 1978. The scientists at DuPont gave a detailed description of a new class of antibiotics called oxazolidinones. Several research programs were carried out by other laboratories in the 1990s. Linezolid was quite an expensive drug in 2009. A treatment course cost £1590 alone. This is not inclusive of hospital stay charges. The price decreased drastically when the medication became generic.

Find reliable Linezolid manufacturers and Linezolid suppliers

Distributors who are keen on monetizing the potential of this drug can connect with reliable Linezolid suppliers on the Pipelinepharma platform. It is a trusted platform and enlists manufacturers only after verifying the quality of their offerings. The distributors can shortlist manufacturers using advanced search filters. It is quite easy to find partners in the global pharma industry if you rely on a platform such as Pipelinepharma.

Interested in Subscription?

Please fill out form and send us your specific requirements, and we will get back to you as soon as possible